<DOC>
	<DOCNO>NCT01592578</DOCNO>
	<brief_summary>The purpose study evaluate efficacy two different endoscopic treatment gastroesophageal varix patient liver cirrhosis : ligation versus ligation plus sclerotherapy addition cyanoacrylates</brief_summary>
	<brief_title>The Research Evaluation Clinical Procedures Gastroesophageal Varices Patients With Liver Cirrhosis</brief_title>
	<detailed_description>Gastroesophageal variceal bleeding , often result portal hypertention , know one frequent death cause patient liver cirrhosis . When patient bleeding episode , 's likely he/she develop another one future . Endoscopic treatment ligation , sclerotherapy cyanocrylates prove decrease risk re-bleeding . The purpose study evaluate efficacy two different endoscopic treatment patient gastric esophageal varix liver cirrhosis : In addition cyanoacrylates , ligation versus ligation plus sclerotherapy .</detailed_description>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Patients portal hypertension cause liver cirrhosis present acute recent episode gastroesophageal variceal bleed previously receive endoscopic treatment ligation cyanoacrylate . Diagnosis liver cirrhosis mixed cirrhosis base result liver biopsy biochemical test liver image ultrasonography . The extent varix range Moderate Severe . The age patient range 18 72 year old . Patients cause portal hypertention ( CTPV , BuddChiari syndrome , etc . ) Patients severe systemic disease ( renal failure , heart failure , carcinoma liver cancer , etc . ) Patients contraindication ligation , sclerotherapy cyanoacrylate . Patients previously receive shunt devascularization operation , TIPS . Patients portosystemic shunt accord result CT scan .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>gastroesophgeal variceal bleeding</keyword>
	<keyword>liver cirrhosis</keyword>
	<keyword>portal hypertension</keyword>
</DOC>